SCHEMBL20530703

SCHEMBL20530703

Fc1cnc2c3c(ccc2c1)CN(CCc1ccccc1)CO3

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
OPRM1 P35372 3/20 0.35
OPRD1 P41143 2/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
FAAH O00519 1/20 0.34
SIGMAR1 Q99720 2/20 0.34
DRD2 P14416 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
OPRK1 P41145 2/20 0.33
SLC6A3 Q01959 1/20 0.33
TP53 P04637 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20530728 0.82 CYP1A2 (0.46) CYP1A2MAPTKDM4ELMNAGAA
SCHEMBL20530692 0.71 HSD17B10 (0.36) KDM4ELMNA
SCHEMBL11712332 0.67 CYP1A2 (0.44) CYP1A2MAPTGAADRD2HTR2A
SCHEMBL11709331 0.66 KCNH2 (0.50) CYP1A2MAPTGAASIGMAR1DRD2
SCHEMBL11707511 0.65 CYP1A2 (0.42) CYP1A2MAPTSIGMAR1DRD2HTR2A
SCHEMBL20530724 0.64 HTR2A (0.46) LMNAHTTDRD2HTR2A
SCHEMBL30322109 0.63 SLC6A3 (0.50) SIGMAR1DRD2SLC6A3
Oxalic Acid SCHEMBL11719164 0.62 POLB (0.48) MAPTKDM4ELMNAGAASIGMAR1
SCHEMBL30134682 0.62 HRH3 (0.51) SIGMAR1DRD2TP53KCNH2
SCHEMBL21160632 0.62 CYP1A2 (0.52) CYP1A2MAPTKDM4ETDP1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3388419-A1 GLI1 INHIBITORS AND USES THEREOF Leadiant Biosciences SA (CH) 2018-10-17 EP claimed
EP-3388419-A1 GLI1 INHIBITORS AND USES THEREOF Leadiant Biosciences SA (CH) 2018-10-17 EP disclosed